Malaysia has stopped the use of hydroxychloroquine to treat Covid-19 as data showed that it had no effect…

..

Health director-general Datuk Dr Noor Hisham Abdullah said the decision was made after data collected from 500 cases showed the medicine had no effect on those infected with the virus.

NST

Dr Noor Hisham: Malaysia drops use of hydroxychloroquine for Covid-19

By Teoh Pei Ying – June 22, 2020 @ 7:14pm

PUTRAJAYA: Malaysia has stopped using hydroxychloroquine against Covid-19 as the decades-old malaria medicine has been proven to be ineffective on the coronavirus.

Health director-general Datuk Dr Noor Hisham Abdullah said the decision was made after data collected from 500 cases showed the medicine had no effect on those infected with the virus.

“It has been used on Covid-19 patients as an off-label medication at the early stage because it has anti-inflammatory properties.

“We were also informed there was a 30 per cent complication rate to the heart and eye, so we had to monitor the usage,” he said at the daily Covid-19 press conference today.

Dr Noor Hisham said the ministry still studied the effectiveness of other medications including drugs used for HIV, lopinavir/ritonavir.

With Malaysia’s recovery rate at more than 95 per cent now, he said it’s difficult for the Health Ministry to run clinical trial of remdesivir on Covid-19.

“We do not have enough patients to test the medicine, although we have been identified by the World Health Organisation as one of the centres for the clinical trial.

“Now, our recovery rate is more than 95 per cent and the death rate is at 1.41 per cent which is good for our country,” he said, adding he hoped the promising development would continue in treating and preventing any fatality related to Covid-19.

Dr Noor Hisham also said the ministry would conduct a research soon to check antibodies of those who had recovered from Covid-19.

“It was reported the antibody would only last for about three months in the Covid-19 patients, hence, we will soon conduct a research to check whether they still have the antibodies,” he said.

https://www.nst.com.my/news/nation/2020/06/602538/dr-noor-hisham-malaysia-drops-use-hydroxychloroquine-covid-19

..

Malaysia’s mortality rate for Covid-19, which stands at 1.41 per cent, is much lower than some countries which have reported rates of 4.6 per cent or 5.6 per cent.

https://www.nst.com.my/news/nation/2020/04/582849/malaysias-covid-19-mortality-rate-lower-many-countries

..

Malaysia still using hydroxychloroquine to treat COVID-19 patients; health ministry monitoring side effects

26 May 2020 10:41PM (Updated: 26 May 2020 10:50PM)

KUALA LUMPUR: Malaysia’s health ministry will continue to use hydroxychloroquine in trials to treat COVID-19 patients, said its director-general Noor Hisham Abdullah on Tuesday (May 26), adding that authorities will closely monitor any side effects.

The anti-malaria drug is known to cause several side effects such as irregular heartbeat and blurred vision. The World Health Organization (WHO) said on Monday that it is suspending testing the drug in COVID-19 patients due to safety concerns.

“As you may know, it has side effects, which vary from person to person, so there needs to be close monitoring by doctors,” Dr Noor Hisham told reporters at a media conference. 

“For example, if a patient has rapid heartbeat, then we will immediately stop usage of the drug in order to prevent heart failure and so on.”

Dr Noor Hisham said hydroxychloroquine is being used to prevent the coronavirus infection from becoming worse at an early stage.

He added that healthcare experts are gathering data, to determine if the use of the drug has been effective.

“The experts are still studying how to prevent existing side effects and avoid high dosage. Let us wait for the literature review which will be issued by the World Health Organization in mid-June,” he said.

For more:

https://www.channelnewsasia.com/news/asia/covid-19-malaysia-hydroxychloroquine-still-using-treatment-12771770

..

..

Antimalarial Drug Helped Stop Covid-19 Patients From Worsening: DG

By CodeBlue

A whopping 88% of Malaysia’s coronavirus cases are in the first two early stages.

KUALA LUMPUR, April 7 — Antimalarial medicine hydroxychloroquine may have helped prevent early Covid-19 patients from deteriorating into conditions that require intensive care or ventilator support, health authorities said.

Health director-general Dr Noor Hisham Abdullah said the Ministry of Health (MOH) has been using hydroxychloroquine, which has anti-inflammatory properties, since the coronavirus outbreak began in Malaysia.

“We monitor the side effects, but the impact we see is on Categories 1 and 2, when they did not deteriorate into Categories 4 and 5,” Dr Noor HIsham told a press conference.

“So, we feel that the medicine can help in terms of inflammation. So, fewer of our patients now enter ICU (intensive care unit) or need ventilator support. If you look now, only 5 per cent enter ICU, compared to 10 per cent in other countries.”

About 30 per cent of Covid-19 patients under ICU in Malaysia have recovered, he said, while 6.2 per cent of ICU patients succumb to coronavirus.

According to the DG, the first stage of Covid-19 is testing positive without symptoms; the second stage shows mild symptoms; the third stage has pneumonia, but doesn’t need oxygen; the fourth stage has pneumonia and needs oxygen; while the fifth stage needs ventilator support.

A whopping 88 per cent of Malaysia’s coronavirus cases are in the first two early stages, 7 per cent in the third stage, and 5 per cent in the two most severe stages. Malaysia has confirmed nearly 4,000 Covid-19 cases to date, including 63 fatalities.


https://codeblue.galencentre.org/2020/04/07/antimalarial-drug-helped-stop-covid-19-patients-from-worsening-dg/

..

NST

Malaysia’s Covid-19 mortality rate lower than many countries

By Meera MurugesanDawn Chan – April 9, 2020 @ 6:47pm

PUTRAJAYA: Malaysia’s mortality rate for Covid-19, which stands at 1.58 per cent, is much lower than some countries which have reported rates of 4.6 per cent or 5.6 per cent.

Health director-general Datuk Dr Noor Hisham Abdullah said this lower rate was indicative of the quality of services offered at Malaysia’s wards and intensive care units (ICU).

“Our intensive care specialists are treating patients well. We must also remember that 88 per cent of patients with Covid-19 only have mild symptoms or no symptoms at all,” he said.

For patients who have either mild symptoms or were asymptomatic, they are also isolated for 14 days, treated and subject to repeated testing. Their results have to be consistently negative for a period of over 24 hours before they can be discharged.

https://www.nst.com.my/news/nation/2020/04/582849/malaysias-covid-19-mortality-rate-lower-many-countries

..

..

This entry was posted in Uncategorized. Bookmark the permalink.

3 Responses to Malaysia has stopped the use of hydroxychloroquine to treat Covid-19 as data showed that it had no effect…

  1. E Lye says:

    I hope he remembers this statement ““As you may know, it has side effects, which vary from person to person, so there needs to be close monitoring by doctors,” Dr Noor Hisham told reporters at a media conference. ” when they roll out any one-size-fits-all-no-proven-cause-of-autism-mercury-and-aluminium-containing COVID vaccine.

  2. Pingback: Hydroxychloroquine and the danger of acting without evidence… | weehingthong

  3. Pingback: Hydroxychloroquine: All my posts… | weehingthong

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s